Latham & Watkins represented the underwriters in the offering. HollyFrontier Corporation has announced that it has priced an offering of US$750 million aggregate principal amount of […]
HollyFrontier’s $750 Million Senior Notes Offering
Emerson Electric’s $750 Million Notes Offering
Davis Polk advised the representatives of the underwriters in the offering. Emerson Electric Co. executed its offering of $750 million aggregate principal amount of 0.875% notes […]
Three Oaks Hospice’s Acquisition Of Hospice Partners Of Kansas
Bass, Berry & Sims advised Addus HomeCare Corporation on the deal. Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and […]
Nuvei Corporation’s $805 Million Initial Public Offering
Davis Polk advised Nuvei Corporation in the offering. Nuvei Corporation executed its initial public offering of 30,961,539 subordinate voting shares for an aggregate amount of approximately […]
Bright Health’s $500 Million Series E Funding Round
Debevoise & Plimpton LLP advised Blackstone in the transaction. Bright Health Inc. closed a $500 million Series E funding round with significant investments by funds and […]
BBVA Mexico’s $500 Million Notes Offering
White & Case LLP has advised the dealers in connection with the offering. Leading Mexican financial institution BBVA Mexico completed its issuance of US$500 million of […]
Athira Pharma’s IPO
Wilson Sonsini Goodrich & Rosati advised Athira Pharma, Inc. on the deal. Athira Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing small molecules to restore […]
Amwell’s $853 Million Initial Public Offering
Davis Polk advised American Well Corporation (“Amwell”) in connection with its initial public offering. American Well Corporation (“Amwell”) executed its initial public offering of 47,405,555 shares […]
Odyssey Investment Partners’ Acquisition of ProPharma Group
Latham & Watkins LLP advised Odyssey in the transaction. Odyssey Investment Partners (Odyssey) has entered into an agreement to acquire ProPharma Group from Linden Capital Partners. […]
Pactiv Evergreen’s $574 Million Initial Public Offering
Davis Polk advised Pactiv Evergreen Inc. on the deal. Pactiv Evergreen Inc. (formerly known as Reynolds Group Holdings Limited) executed its $574 million initial public offering […]
Sumo Logic’s $325.6 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. Sumo Logic, Inc. executed its $325.6 million initial public offering of 14,800,000 shares of […]
Chewy’s $282 Million Public Offering
Davis Polk advised the underwriter in connection with the offering. Chewy, Inc. executed its $282 million public offering of 5,100,000 shares of Class A common stock. […]